Examples of using Finasteride in English and their translations into Thai
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Finasteride is a 4- azotypic compound, which is a specific inhibitor of intracellular enzyme- II type 5a- reductase in the process of testosterone metabolism.
It's also important to note this hormone's androgenicity cannot be reduced by the use of a 5-alpha reductase inhibitor like Finasteride;
Even use of 5-alpha reductase inhibitors such as finasteride doesn't have an effect with Superdrol because the methyldrostanolone hormone resists metabolism through that enzyme.
Dutasteride inhibits two of the three isoforms of 5-alpha reductase, I and II, whereas finasteride only inhibits type II, and has a much shorter half-life.
Women should not handle crushed or broken Finasteride tablets USP when they are pregnant or may potentially be pregnant because of the possibility of absorption of Finasteride and the subsequent potential risk to a male fetus.
This is important for performance enhancers as DHT based anabolic steroids have specific side-effects that may occur that can largely be remedied with the use of a 5-AR inhibitor such as Finasteride.
Finasteride tablets USP are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets have not been broken or crushed.
In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects.
In a animal label of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with the exact same efficacy to finasteride, but without producing any decline in muscular mass or anti-androgenic negative effects.
It may be used alone or in combination with other medicines such as an alpha-blocker to treat BPH. For men with hair loss, finasteride will increase the number of scalp hairs but will not increase the amount of body hair.
The concurrent use of a 5-alpha reductase inhibitor such as finasteride or dutasteride will interfere with site-specific reduction of nandrolone action, considerably increasing the tendency of nandrolone to produce androgenic side effects. Reductase inhibitors should be avoided with nandrolone if low androgenicity is desired.
The concurrent use of a 5- alpha reductase inhibitor such as finasteride or dutasteride will interfere with site-specific reduction of nandrolone action, considerably increasing the tendency of nandrolone to produce androgenic side effects. Reductase inhibitors should be avoided with nandrolone if low androgenicity is desired.
Finasteride blocks the action of an enzyme called 5-alpha-reductase. This enzyme changes testosterone to another hormone that causes the prostate to grow or hair loss in males. It will increase testosterone levels in the body, which decreases prostate size and increases hair growth on the scalp.
In addition to inhibiting 5α-reductase, finasteride has also been found to competitively inhibit 5β-reductase(AKR1D1), although its affinity for the enzyme is substantially less than for 5α-reductase(an order of magnitude less than 5α-reductase type I) and hence is unlikely to be of clinical significance.
Finasteride is an inhibitor of steroid Type II 5a-reductase, that works by decreasing the amount of a natural body hormone dihydrotestosterone(DHT) that causes growth of the prostate, and is used to treat symptoms of benign prostatic hyperplasia(BPH) in men with an enlarged prostate.
It was removed from the list effective January 1, 2009, after improvements in testing methods made the ban unnecessary. Athletes who used finasteride and were banned from international competition include skeleton racer Zach Lund, bobsledder Sebastien Gattuso, footballer Romário and ice hockey goaltender José Théodore.
By blocking DHT production, finasteride reduces androgen activity in the scalp. In the prostate, inhibition of 5α-reductase reduces prostate volume, which improves BPH and reduces risk of prostate cancer. Inhibition of 5α-reductase also reduces epididymal weight, and decreases motility and normal morphology of spermatozoa in the epididymis.
Unlike triple inhibitors of all three isoenzymes of 5α-reductase like dutasteride which can reduce DHT levels in the entire body by more than 99%, finasteride does not completely suppress DHT production because it lacks significant inhibitory effects on the 5α-reductase type I isoenzyme, with 100-fold less affinity for I as compared to II.
Finasteride is a 5α-reductase inhibitor, specifically the type II and III isoenzymes. By inhibiting 5α-reductase, finasteride prevents conversion of testosterone to dihydrotestosterone(DHT) by the type II and III isoenzymes, resulting in a decrease in serum DHT levels by about 65-70% and in prostate DHT levels by up to 85-90%, where expression of the type II isoenzyme predominates.
Six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment. If the drug is discontinued, any therapeutic benefits reverse within about 6-8 months. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start of urination, and decreased urinary flow.